DaVita Inc. (NYSE: DVA) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $10.9B. The Maz Rating grades it against the other companies in its sector.
DaVita Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $173.00, DaVita Inc. trades at 13.3x trailing earnings and 0.8x sales, with an EV/EBITDA of 8.5. Over the last twelve months it generated about $14.2B of revenue and $819M of net income. It runs a gross margin of 31.0%, an operating margin of 14.8% and a net margin of 6.5%. It shows return on equity of -133.2%, return on invested capital of 10.7% and a free cash flow yield of 11.9%. On the balance sheet: a debt-to-equity ratio of -22.66 and a current ratio of 1.41. Over the past 52 weeks the share price ranged from $101.00 to $247.49, with a beta of 0.86.
DaVita Inc. does not currently pay a dividend.
23 Wall Street analyst ratings cover the stock: 10 Buy, 12 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.